BPC-157 Made in USA — Third-Party Verified
High-purity BPC-157 engineered for advanced cell culture and preclinical tissue regeneration assays. Sourced through strict domestic synthesis pathways, PX1 Research provides fully documented, lot-specific COAs verified by ISO 17025 accredited laboratories.
Quick answer
High-purity BPC-157 engineered for advanced cell culture and preclinical tissue regeneration assays. Sourced through strict domestic synthesis pathways, PX1 Research provides fully documented, lot-specific COAs verified by ISO 17025 accredited laboratories.
Key takeaways
- Body Protection Compound 157 ([BPC-157](/research-peptides/bpc-157)) is a synthetic pentadecapeptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) derived from a partial sequence of human gastric juice protein.
- The primary therapeutic role under investigation for [BPC-157](/research-peptides/bpc-157) is its function as a tissue repair peptide.
- Soft tissue injury models—specifically involving avascular or hypovascular structures such as tendons and ligaments—present significant challenges in regenerative medicine due to their limited endogenous healing capacity.
- Beyond connective tissue applications, [BPC-157](/research-peptides/bpc-157) exhibits significant cytoprotective capabilities across skeletal muscle and gastrointestinal tissue models.
Overview of BPC-157 Synthesis and Domestic Quality Standards
Body Protection Compound 157 (BPC-157) is a synthetic pentadecapeptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) derived from a partial sequence of human gastric juice protein. In biological research, BPC-157 is evaluated for its high stability in aqueous solutions and its pleiotropic cytoprotective activity. Obtaining consistent experimental outcomes in tissue engineering and cellular repair assays requires a highly pure, contaminant-free research compound. When evaluating suppliers, securing high-purity BPC-157 made in USA ensures that solid-phase peptide synthesis (SPPS) adheres to strict quality controls, preventing batch-to-batch variability that can compromise quantitative assay data.
PX1 Research prioritizes domestic manufacturing to eliminate the risk of residual heavy metals, TFA salts, and unreacted peptide fragments frequently associated with unvetted overseas supply chains. Each batch synthesized in our cGMP-compliant facilities undergoes rigorous quality assurance steps. By utilizing domestic facilities, PX1 Research maintains direct oversight over synthesis parameters, purification steps, and chain-of-custody protocols before dispatching samples from our fulfillment centers in California and Arizona.
Molecular Mechanism: Angiogenesis and Cellular Migration
The primary therapeutic role under investigation for BPC-157 is its function as a tissue repair peptide. Preclinical studies suggest that the compound accelerates repair pathways in damaged soft tissues and mucosal membranes by triggering localized angiogenesis and promoting directed cellular migration to injury sites. In vitro assays demonstrate that BPC-157 upregulates the expression of Vascular Endothelial Growth Factor (VEGF) and activates Vascular Endothelial Growth Factor Receptor 2 (VEGFR2), initiating the sprouting of new microvessels essential for delivering oxygen and nutrients to ischemia-stressed tissues.
In addition to angiogenic signaling, in vitro data indicate that BPC-157 interacts directly with the focal adhesion kinase (FAK) and paxillin pathway. This interaction promotes the structural reorganization of the cytoskeleton within tendon fibroblasts and endothelial cells. By promoting migration speed and cell survival under oxidative stress conditions, the peptide accelerates the recruitment of progenitor cells to damaged matrices without inducing systemic toxicity or unregulated cell proliferation in healthy controls.
Preclinical Evidence in Tendon and Ligament Repair Models
Soft tissue injury models—specifically involving avascular or hypovascular structures such as tendons and ligaments—present significant challenges in regenerative medicine due to their limited endogenous healing capacity. Rodent models of transected or surgically clipped Achilles tendons demonstrate that administration of BPC-157 enhances biomechanical functional recovery. Researchers observing explanted tissue noted increased fibroblast density, organized collagen fiber deposition (transitioning from Type III to organized Type I collagen), and superior tensile strength compared to untreated controls.
Similarly, in animal models targeting medial collateral ligament (MCL) tears, treatment with BPC-157 led to accelerated structural outgrowth and tissue bridge establishment. The observed acceleration of ligamentous healing is attributed to the peptide's ability to maintain early matrix metalloproteinase (MMP) activity while subsequently promoting matrix deposition, ensuring that tissue remodeling occurs in a structured, functional alignment rather than producing disassociated scar tissue. Investigators can review detailed experimental frameworks within our research library hub.
Muscular and Gastrointestinal Cytoprotection Research
Beyond connective tissue applications, BPC-157 exhibits significant cytoprotective capabilities across skeletal muscle and gastrointestinal tissue models. In preclinical crushed or transected muscle tissue experiments, application of the pentadecapeptide promoted myocyte regeneration, reduced inflammatory cell infiltration, and preserved muscle mass. This protective effect appears mediated in part through the modulation of nitric oxide (NO) synthase expression, balancing inducible NO (iNOS) and endothelial NO (eNOS) during acute inflammatory cascades.
Gastrointestinal models represent another major domain of BPC-157 investigation. In vitro and in vivo models of inflammatory bowel disease (IBD), NSAID-induced gastric ulcers, and intestinal anastomotic leaks show that BPC-157 preserves epithelial integrity. Preclinical rodent models suggest that the peptide enhances the expression of tight junction proteins, such as occludin and zonula occludens-1 (ZO-1), thereby restoring mucosal barrier function and preventing bacterial translocation across compromised intestinal walls.
Comparative Analysis: BPC-157 vs. TB-500, GHK-Cu, and KPV
When designing tissue repair and cellular protection experiments, researchers frequently compare BPC-157 against other leading peptides within the regenerative class. While BPC-157 operates primarily through localized VEGFR2 activation, FAK/paxillin cell migration pathways, and nitric oxide modulation, complementary compounds utilize distinct biochemical pathways to facilitate tissue homeostasis. Understanding these mechanical nuances allows principal investigators to select the appropriate candidate or evaluate synergistic multi-peptide protocols in preclinical models.
For instance, TB-500 (a synthetic fragment of Thymosin Beta-4) acts primarily as an actin-sequestering protein, promoting cell motility and systemic cell migration across broad tissue types. In contrast, GHK-Cu functions as a tripeptide-copper complex that regulates gene expression for extracellular matrix remodeling and glycosaminoglycan synthesis. Furthermore, researchers investigating gut mucosal inflammation or broad anti-inflammatory cascades often pair cytoprotective peptides with tripeptides like KPV, which directly targets the NF-kB inflammatory pathway. Reviewing these distinct targets assists labs in refining their target-specific protocols; consult our guide on pentadecapeptide mechanisms for expanded biochemical pathways.
Analytical Chemistry: HPLC and Mass Spectrometry Lot Verification
To ensure that experimental results reflect the true biological profile of the target compound rather than impurities or synthesis artifacts, analytical chemistry verification is non-negotiable. PX1 Research enforces a strict multi-tier quality assurance protocol. Every single lot of synthesized peptide undergoes High-Performance Liquid Chromatography (HPLC) coupled with Electrospray Ionization Mass Spectrometry (ESI-MS) to verify both chemical purity and exact molecular weight.
Our HPLC analysis guarantees a chromatographic purity profile of equal to or greater than 99.0%, ensuring that truncated sequences, deletion peptides, and organic synthesis reagents are removed during liquid-phase purification. Electrospray Mass Spectrometry confirms the exact monoisotopic mass of the pentadecapeptide (1419.5 Da), verifying sequence identity before release. These raw analytical datasets are compiled into a lot-specific Certificate of Analysis (COA), issued directly by an independent, ISO 17025 accredited analytical laboratory.
Endotoxin Testing and Sterility Standards for In Vitro Assays
Bacterial endotoxins (lipopolysaccharides, or LPS) pose a severe threat to the validity of cell culture and preclinical tissue models. Elevated endotoxin concentrations introduce uncontrolled inflammatory signaling through Toll-like Receptor 4 (TLR4), masking peptide-specific responses, causing non-specific cell mortality, and rendering biological assays irreproducible.
PX1 Research tests every batch of BPC-157 for endotoxins using kinetic chromogenic Limulus Amebocyte Lysate (LAL) testing protocols. We enforce an industry-leading endotoxin limit threshold of under 0.01 EU/mg. This guarantees that our research compounds are suitable for sensitive primary cell cultures, 3D organoid models, and delicate in vitro vascular assays without introducing immunogenic confounding variables. Detailed analysis on endotoxin impacts can be found in our technical article on angiogenesis preclinical models.
Storage, Stability, and Laboratory Reconstitution Protocols
Proper handling and storage are critical to preserving the primary structure and biological activity of lyophilized BPC-157. Upon delivery to the laboratory, unopened vials containing lyophilized peptide cake should be stored in a desiccated freezer environment at -20°C or -80°C for long-term stability. Under these conditions, the dry peptide remains stable for up to 24 months without significant degradation.
For reconstitution in a laboratory setting, allow the vial to equilibrate to room temperature before adding a sterile solvent to prevent moisture condensation. Reconstitute the cake using sterile bacteriostatic water or phosphate-buffered saline (PBS, pH 7.4), depending on assay requirements. Gently swirl or invert the vial to dissolve the compound; never vortex or vigorously agitate the solution, as shear forces can disrupt peptide tertiary structure. Once reconstituted, liquid aliquots should be stored at 4°C and used within 30 days, or frozen in single-use aliquots at -20°C to avoid repeated freeze-thaw cycles.
Sourcing USA-Synthesized Peptides for Institutional Research
Institutional laboratories, academic research departments, and private biotechnology facilities require streamlined procurement options backed by documented compliance. PX1 Research simplifies institutional sourcing by offering verified, domestically synthesized peptides with batch-level traceability. Academic and commercial laboratories seeking bulk quantities for extended study designs can access specialized terms via our wholesale lab account portal.
All orders ship directly from our climate-controlled domestic distribution hubs in California and Arizona. Orders placed Monday through Friday before cut-off times are processed for same-day dispatch. This guarantees rapid delivery and reduces thermal degradation risks during transit, ensuring your research team receives stable, high-integrity compounds ready for immediate experimental deployment.
Frequently Asked Questions
Where is PX1 Research's BPC-157 synthesized?
PX1 Research sources its BPC-157 exclusively through high-purity solid-phase synthesis facilities located within the United States. Domestic manufacturing ensures strict adherence to cGMP quality standards and eliminates batch variability.
How is the purity of BPC-157 verified?
Every lot undergoes independent, third-party testing at an ISO 17025 accredited laboratory. Purity and identity are confirmed using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS), ensuring a minimum chromatographic purity of 99%.
What are the endotoxin limits for PX1 Research BPC-157?
Our BPC-157 is batch-tested for bacterial endotoxins using kinetic LAL assays, strictly maintaining endotoxin levels below 0.01 EU/mg to ensure safety in sensitive cell cultures and in vitro models.
Is BPC-157 approved for human consumption or therapeutic use?
No. BPC-157 provided by PX1 Research is strictly a research compound intended solely for laboratory in vitro, ex vivo, and preclinical animal research. It is not for human or veterinary use, consumption, injection, or medical treatment.
What biological pathways are primary targets of BPC-157 in research?
Preclinical models show that BPC-157 interacts with the VEGF signaling pathway to promote angiogenesis, upregulates FAK/paxillin to drive fibroblast cell migration, and modulates nitric oxide (NO) synthase activity during tissue repair.
How should lyophilized BPC-157 be stored upon arrival?
Lyophilized BPC-157 should be kept in a desiccated freezer at -20°C for long-term storage (stable up to 24 months). Protect the vial from direct light and moisture exposure.
What is the recommended reconstitution procedure for lab assays?
Reconstitute the lyophilized cake using sterile bacteriostatic water or sterile PBS (pH 7.4). Allow the vial to reach room temperature before solvent addition, and gently swirl until dissolved. Avoid vortexing.
How does BPC-157 differ from TB-500 in tissue repair research?
While BPC-157 acts primarily via localized VEGFR2 activation, cellular adhesion (FAK/paxillin), and mucosal cytoprotection, TB-500 (Thymosin Beta-4 fragment) functions through actin sequestration to promote broader systemic cell migration.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.